More on SGEN

- Summary
- Chart
- Profile
- Historical


- Earnings (-171.4% Growth)
- Ratings (3.0 Score)
- Holders
- FDA Archive


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (10/30/15 *Est.)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

SGEN Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 79.01M
Short-term investments
Interest receivable
Accounts receivable 45.25M
Prepaid expenses and other current assets 11.85M
Total current assets 354.12M
Property and equipment, net 43.64M
Long-term investments
Other non-current assets
Total assets 407.82M
Liabilities and Stockholders' Equity
Accounts payable and accrued liabilities
Current portion of deferred revenue 47.75M
Total current liabilities 133.76M
Long-term liabilities
Deferred revenue, less current portion 90.22M
Deferred rent and other long-term liabilities 4.22M
Total long-term liabilities 94.44M
Commitments and contingencies 0
Stockholders' equity
Preferred stock, $0.001 par value, 5,000 shares authorized; none issued and outstanding 0
Common stock, $0.001 par value, 250,000 shares authorized at June 30, 2011 and 150,000 shares authorized at December 31, 2010; 114,419 shares issued and outstanding at June 30, 2011 and 101,607 shares issued and outstanding at December 31, 2010 125K
Additional paid-in capital 1.06B
Accumulated other comprehensive loss 12K
Accumulated deficit -875.64M
Total stockholders' equity 179.62M
Total liabilities and stockholders' equity 407.82M